Not recruiting
Hormone-refractory prostate cancer
Not recruitingStudy of ODM-208 (opevesostat) safety and effectiveness in patients with metastatic castration-resistant prostate cancer
Registered drugNo placebo
Study of ODM-208 (opevesostat) safety and effectiveness in patients with metastatic castration-resistant prostate cancer
Registered drugNo placebo
- Disease:Hormone-refractory prostate cancer
- Substances:ODM-208Opevesostat+1
Countries:
Finland
Finland- Participants:18–64 years · 65+ years
- Substances:ODM-208

